1. Home
  2. KR vs CRNX Comparison

KR vs CRNX Comparison

Compare KR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kroger Company (The)

KR

Kroger Company (The)

HOLD

Current Price

$70.92

Market Cap

38.9B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$42.59

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KR
CRNX
Founded
1883
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9B
4.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
KR
CRNX
Price
$70.92
$42.59
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$72.75
$75.78
AVG Volume (30 Days)
7.2M
1.0M
Earning Date
03-05-2026
02-26-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$147,225,000,000.00
$1,535,000.00
Revenue This Year
$3.78
$499.13
Revenue Next Year
$2.10
$893.14
P/E Ratio
$60.44
N/A
Revenue Growth
N/A
47.74
52 Week Low
$58.60
$24.10
52 Week High
$74.90
$57.99

Technical Indicators

Market Signals
Indicator
KR
CRNX
Relative Strength Index (RSI) 68.70 36.05
Support Level $67.44 $43.94
Resistance Level $72.24 $48.58
Average True Range (ATR) 2.02 2.53
MACD 0.67 -0.77
Stochastic Oscillator 75.00 5.33

Price Performance

Historical Comparison
KR
CRNX

About KR Kroger Company (The)

Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: